News & Updates
Filter by Specialty:
ALA-PDT on par with minocycline for moderate-to-severe rosacea
Patients with moderate-to-severe rosacea may benefit from treatment with 5-aminolevulinic acid photodynamic therapy (ALA-PDT), which has shown its efficacy and noninferiority to minocycline in a recent study.
ALA-PDT on par with minocycline for moderate-to-severe rosacea
08 Oct 2023
Too much animal-based protein poses increased AD risk
Frequent intake of high-protein foods in diets, especially those derived from animals, appears to be associated with an increased risk of atopic dermatitis (AD) and allergic sensitization to common house dust mites, according to a study.
Too much animal-based protein poses increased AD risk
28 Sep 2023
Does UV-B phototherapy increase the risk of skin cancer in AD patients?
Ultraviolet (UV)-B phototherapy does not appear to increase the risk of skin cancer in patients with atopic dermatitis (AD), reveals a study.
Does UV-B phototherapy increase the risk of skin cancer in AD patients?
18 Sep 2023
Bimekizumab safe, effective in moderate-to-severe plaque psoriasis
The high clinical response levels achieved with bimekizumab over 48 weeks persist up to week 96 in patients with moderate-to-severe plaque psoriasis, results of the BE RADIANT phase IIIb trial have shown. In addition, those on secukinumab who switched to bimekizumab have achieved similar responses at 96 weeks.
